Jun 06, 2017 04:30 AM EDT
Aspirins are widely known to reducing blood clots in heart attack and stroke patients. However, a study had revealed that aspirins have no effects on atherosclerosis patients that have no recent history of heart attacks or stroke.
According to Medical Xpress, patients with narrowed, hardened arteries condition called atherosclerosis are discovered by a team to have no benefits from aspirin. Researchers from the University of Florida Health were said to study the history records collected in the year between 2003 and mid-2009 of 33,000 atherosclerosis patients to understand aspirin effects further.
With that said, the team then found out that aspirins have no effect on atherosclerosis patients that has no prior heart attack or stroke. Yet, the drug is identified to be effective if the patients have a history of heart attack, stroke or other issues involving arteries. The findings were published in the journal Clinical Cardiology.
However, an associate professor in the UF College of Medicine's department of medicine, Anthony Bavry, M.D., still concluded that clinical trials are needed in order to conclude whether does aspirin have an effect on atherosclerosis patients or not. Bavry then warned that atherosclerosis or peripheral vascular disease patients should not quit aspirin therapy on their own but should consult their physicians first.
On the bright side, The Washington Post reported that low-dosage aspirin intake might aid women in preventing breast cancer. The team then assessed 57,164 women with no breast cancer history. They also discovered that the women who took low-dose aspirin were 16 percent less likely to develop any breast cancer types compared to those 20 percent who didn’t take NSAIDs.
The researchers found out that 1,457 women were diagnosed with breast cancer after seven years. The researchers grouped the women which they said that 23 percent takes a low-dose aspirin (81 milligrams) as 18 percent of them takes ibuprofen. The 11 percent were said to intake full-strength aspirin (325 mg) while the 10 percent were taking COX-2 inhibitor or other nonsteroidal anti-inflammatory drug (NSAID) at least three times a week.
2. 10:56 AM
Price disclosure legislation unlikely to lower drug costs
3. 10:49 AM
Identifying factors that influence mercury levels in tuna
4. 10:44 AM
Emergency caesareans put new mothers at higher risk of developing postnatal depression
2. Jan 22, 2019
From toilet to brickyard: Recycling biosolids to make sustainable bricks
3. Jan 22, 2019
Antarctic krill population contracts southward as polar oceans warm
4. Jan 22, 2019
UMass Amherst materials chemists tap body heat to power 'smart garments'